Alibaba
BABA
NVIDIA
NVDA
Qualcomm
QCOM
4
Microsoft
MSFT
5
ASML Holding
ASML
US Stock MarketDetailed Quotes
RPHCF ROHTO PHARMACEUTICAL CO
- 20.090
- 0.0000.00%
15min DelayTrading Dec 31 16:00 ET
4.58BMarket Cap23.04P/E (TTM)
0.000High0.000Low0Volume0.000Open20.090Pre Close0.00Turnover0.00%Turnover Ratio22.03P/E (Static)228.14MShares21.43152wk High2.63P/B4.58BFloat Cap18.30052wk Low0.20Dividend TTM228.14MShs Float26.374Historical High0.98%Div YieldTTM0.00%Amplitude18.300Historical Low--Avg Price1Lot Size
ROHTO PHARMACEUTICAL CO Key Stats
EPS
According to the latest financial report of ROHTO PHARMACEUTICAL CO, the latest earnings per share (TTM) for the company is 51.95. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: JPY
Quarterly
Loading...
FCF
Interested in knowing about ROHTO PHARMACEUTICAL CO's free cash flow? The latest report shows it as 3.39B. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: JPY
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of ROHTO PHARMACEUTICAL CO shows that the company's current ratio is 1.93, indicating healthy liquidity.
Currency: JPY
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of ROHTO PHARMACEUTICAL CO, the quick ratio is 1.09, indicating that the company can meet its short-term debt obligations.
Currency: JPY
Quarterly
Loading...
ROE
Want to learn more about the financial health of ROHTO PHARMACEUTICAL CO? The latest ROE figure is 4.67%, indicating that the company has stable profitability.
Currency: JPY
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of ROHTO PHARMACEUTICAL CO, the total asset return on investment (ROA) is 2.93%.
Currency: JPY
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check ROHTO PHARMACEUTICAL CO's latest financial report to see how their gross margin is doing - currently at 58.16%.
Currency: JPY
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of ROHTO PHARMACEUTICAL CO, the net profit margin is 13.59%, which is a good sign for its profitability.
Currency: JPY
Quarterly
Loading...
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!